FindMyKOL
Clinical trialNCT01752023TerminatedPhase 2Interventional

A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.

SponsorSidney Kimmel Comprehensive Cancer Center at Johns HopkinsEnrollment3Non-small Cell Lung Cancer Metastatic
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Response rates. Changes in tumor blood flow.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Bayview Medical Center at Johns Hopkins

    Baltimore, Maryland, United States

  • Johns Hopkins University, Skccc

    Baltimore, Maryland, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cisplatin + GemcitabineCisplatin + Gemcitabine with SUBATM-itraconazole
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2013
Primary completion
30 Apr 2014
Completion
30 Apr 2014
Last update posted
17 Oct 2018
Registered enrollment
3
Registry id
NCT01752023
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.